Wearable Sensors and Telemedicine Strategies for Cystic Fibrosis Patients |Biomedgrid

Telemedicine is an emerging medical strategy to monitor patients at home, without hospitalization risks, ensuring continuous care. Cystic Fibrosis (CF) is one of chronic disease that could be monitored for some aspects at home. The advances in Artificial Intelligence (AI) and telemedicine have the potential to increase the accuracy, reduce the costs and extend the reach of screening for pathologies like glaucoma, diabetes, etc. Wearable sensors and other telemedicine strategies were tested for CF patients during the COVID-19 pandemic. The fields of application of Artificial Intelligence (IA) regards multiple aspects of patient's life, from mental status to physical activity. In this mini review, we focused on the most recent telemedicine strategies to improve life quality and care of CF patients.